MLLT10 and breast carcinoma: The non-pseudo gene version of MLLT10 has been documented to be a promoter of tumor cell proliferation, migration, and invasion in NSCLC cell lines (83), and MLLT10P1 is commonly mutated in breast cancer patients (84).